跳至主要内容
临床试验/JPRN-UMIN000046286
JPRN-UMIN000046286已完成未知

Effect of adjuvant chemotherapy on periosteal osteosarcoma: a systematic review - Chemotherapy for periosteal osteosarcoma

ara Medical University0 个研究点目标入组 291 人开始时间: 2021年12月6日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
291

研究概览

简要总结

暂无简介。

研究设计

研究类型
Others,meta-analysis etc

入排标准

年龄范围
ot applicable 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • (1) Patients with periosteal osteosarcoma and distant metastases at the diagnosis were excluded. Patients with no data regarding the prognosis were also excluded. (2) Patients with periosteal osteosarcoma who underwent surgery alone and palliative chemotherapy for distant metastases that occurred during the follow up were classified into the surgery alone group. (3) Regarding the number of deaths, only tumor-related deaths were counted. We also analyzed the risk of local recurrence, distant metastasis, and secondary malignancy. (4) There were no restrictions on the year of publication, targeting only English and Japanese literature.

研究者

发起方
ara Medical University

相似试验